278 related articles for article (PubMed ID: 36153294)
1. Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study.
Fiuza M; Magalhães A; Nobre Menezes M; Costa P; Abreu Ribeiro L; Abreu C; Brás R; Vieira J; Duarte AI; Morais P; Silva B; Costa L; Pinto FJ
Rev Port Cardiol; 2022 Dec; 41(12):979-984. PubMed ID: 36153294
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study.
Kappel C; Rushton M; Johnson C; Aseyev O; Small G; Law A; Ivars J; Dent S
Curr Oncol; 2019 Jun; 26(3):e322-e327. PubMed ID: 31285675
[TBL] [Abstract][Full Text] [Related]
3. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
[TBL] [Abstract][Full Text] [Related]
4. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
[TBL] [Abstract][Full Text] [Related]
5. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
[TBL] [Abstract][Full Text] [Related]
6. Organization and implementation of a cardio-oncology program.
Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
[TBL] [Abstract][Full Text] [Related]
7. Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.
Nobre Menezes M; Tavares da Silva M; Magalhães A; Melica B; Toste JC; Calé R; Almeida M; Fiuza M; Infante de Oliveira E
Rev Port Cardiol; 2024 Jan; 43(1):35-48. PubMed ID: 37482119
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cardiac toxicity of systemic treatments in Moroccan patients followed for localized breast cancer: Prospective observational study of 549 cases.
Haffadi M; Tawfiq N; Dakir M; Boughafour M; Bouchbika Z; Benchakroun N; Jouhadi H; Sahraoui S; Benider A; Krikez I; Benmallek R; Habbal R
Gulf J Oncolog; 2021 Jan; 1(35):59-65. PubMed ID: 33716214
[TBL] [Abstract][Full Text] [Related]
9. Clinical Experience of Patients Referred to a Multidisciplinary Cardiac Oncology Clinic: An Observational Study.
Sulpher J; Mathur S; Graham N; Crawley F; Turek M; Johnson C; Stadnick E; Law A; Wentzell J; Dent S
J Oncol; 2015; 2015():671232. PubMed ID: 26300917
[TBL] [Abstract][Full Text] [Related]
10. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
Parent S; Pituskin E; Paterson DI
Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol.
Díaz-Balboa E; González-Salvado V; Rodríguez-Romero B; Martínez-Monzonís A; Pedreira-Pérez M; Palacios-Ozores P; López-López R; Peña-Gil C; González-Juanatey JR
BMC Cardiovasc Disord; 2021 Apr; 21(1):165. PubMed ID: 33827450
[TBL] [Abstract][Full Text] [Related]
12. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
Rygiel K
Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
[TBL] [Abstract][Full Text] [Related]
13. Cardio-Oncology Care Delivered in the Non-academic Environment.
Arnold AM; Skurka K
Curr Treat Options Oncol; 2022 May; 23(5):762-773. PubMed ID: 35349050
[TBL] [Abstract][Full Text] [Related]
14. Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity.
Čiburienė E; Aidietienė S; Ščerbickaitė G; Brasiūnienė B; Drobnienė M; Baltruškevičienė E; Žvirblis T; Čelutkienė J
J Cardiovasc Dev Dis; 2022 Apr; 9(5):. PubMed ID: 35621845
[TBL] [Abstract][Full Text] [Related]
15. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
[TBL] [Abstract][Full Text] [Related]
16. Tailored to a Woman's Heart: Gender Cardio-Oncology Across the Lifespan.
Chen MH; Epstein SF
Curr Cardiol Rep; 2023 Nov; 25(11):1461-1474. PubMed ID: 37819431
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally?
Yoon GJ; Telli ML; Kao DP; Matsuda KY; Carlson RW; Witteles RM
J Am Coll Cardiol; 2010 Nov; 56(20):1644-50. PubMed ID: 21050974
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology: A Basic, Clinical, and Observational Science Perspective.
Adhikari BB; Shi S; Dimond EP; Shelburne N; Desvigne-Nickens P; Minasian LM
Heart Fail Clin; 2022 Jul; 18(3):515-528. PubMed ID: 35718423
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced cardiotoxicity in children.
Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
